ArticleNature communications2022

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Tianyu Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.